Table 3.
Rates of disabling or fatal stroke and withdrawal or lost to follow-up
SAMMPRIS trial | Disabling or fatal stroke within 30 days | Disabling or fatal stroke beyond 30 days | Rate of withdrawal or lost to follow-up |
Medical group (n=227) |
4 (1.8%) | 14 (6.2%) | 24 (10.5%) |
Stenting group (n=224) |
14 (6.2%) | 5 (2.2%) | 10 (4.4%) |